Serum levels of desacyl ghrelin in patients with schizophrenia on clozapine monotherapy

被引:6
|
作者
Wysokinski, Adam [1 ]
Kowalski, Marek L. [2 ]
Kloszewska, Iwona [1 ]
机构
[1] Med Univ Lodz, Dept Old Age Psychiat & Psychot Disorders, PL-92216 Lodz, Poland
[2] Med Univ Lodz, Dept Immunol Rheumatol & Allergy, PL-92216 Lodz, Poland
关键词
clozapine; desacyl ghrelin; metabolic syndrome; schizophrenia; weight gain; X-RAY ABSORPTIOMETRY; ATYPICAL ANTIPSYCHOTICS; BODY-COMPOSITION; METABOLIC SYNDROME; ACYLATED GHRELIN; OLANZAPINE; RISPERIDONE; RECEPTOR; STOMACH; LEPTIN;
D O I
10.1111/pcn.12199
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
AimDesacyl ghrelin is a hormone that might be a functional inhibitor of ghrelin, a potent hunger-stimulating peptide. MethodsWe determined fasting serum desacyl ghrelin levels in 24 subjects with schizophrenia on clozapine monotherapy and 24 healthy, age- and sex-matched controls. Biochemical and anthropometric measurements were combined with body composition determined using bioelectric impedance analysis. ResultsThere were no differences in desacyl ghrelin levels between patients taking clozapine and the control group (272.09137.96 vs 259.62 +/- 140.91pg/mL, z=0.17, P=0.87). In the clozapine group, there were no differences between men and women for ghrelin levels (246.66 +/- 123.17 vs 295.39 +/- 151.77pg/mL, z=-0.98, P=0.32). In the clozapine group, fasting serum levels of ghrelin negatively correlated with waist-to-hip ratio (WHR) (r=-0.45, P=0.03) and ionized calcium (r=-0.45, P=0.03). Levels of ghrelin were lower in patients with WHR above World Health Organization-defined cut-off points (246.84 +/- 114.34 [Q1=152.18, Q2=220.92, Q3=327.85] vs 400.30 +/- 123.36 [Q1=283.73, Q2=414.03, Q3=485.8] pg/mL, z=2.52, P=0.01). In the clozapine group, there were no correlation with age, height, weight, body mass index, abdominal circumference, waist circumference, hip circumference, WHR, blood pressure, total cholesterol, high-density lipoproteins, low-density lipoproteins, triglycerides, uric acid, homocysteine, glucose, insulin, clozapine dose, duration of treatment with antipsychotics, duration of treatment with clozapine, total fat, target fat, basal metabolic rate, target weight, lean weight, body water, homoeostasis model assessment of insulin resistance (HOMA) 1-IR, HOMA2-IR and quantitative insulin sensitivity check index. ConclusionBased on our results, we cannot conclude that treatment with clozapine affects levels of desacyl ghrelin. Also, in our study population we did not confirm previously described associations between desacyl ghrelin and various metabolic parameters.
引用
收藏
页码:833 / 840
页数:8
相关论文
共 50 条
  • [1] Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy
    Wysokinski, Adam
    Kazmierski, Jakub
    Kloszewska, Iwona
    [J]. METABOLIC BRAIN DISEASE, 2015, 30 (02) : 529 - 535
  • [2] Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy
    Adam Wysokiński
    Jakub Kaźmierski
    Iwona Kłoszewska
    [J]. Metabolic Brain Disease, 2015, 30 : 529 - 535
  • [3] Fasting Serum Levels of Neuropeptide Y in Patients With Schizophrenia on Clozapine Monotherapy
    Wysokinski, Adam
    [J]. CLINICAL NEUROPHARMACOLOGY, 2015, 38 (01) : 18 - 22
  • [4] Blood serum levels of CART peptide in patients with schizophrenia on clozapine monotherapy
    Wysokinski, Adam
    Kloszewska, Iwona
    [J]. PSYCHIATRY RESEARCH, 2014, 220 (1-2) : 170 - 174
  • [5] Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
    Adam Wysokiński
    Iwona Kłoszewska
    [J]. Neurochemical Research, 2013, 38 : 2056 - 2062
  • [6] Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
    Wysokinski, Adam
    Kloszewska, Iwona
    [J]. NEUROCHEMICAL RESEARCH, 2013, 38 (10) : 2056 - 2062
  • [7] Uric acid levels in patients with schizophrenia on clozapine monotherapy
    Wysokinski, Adam
    Kloszewska, Iwona
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 2015, 69 (06) : 1735 - 1740
  • [8] Serum Levels of PYY(1-36) Peptide in Patients with Schizophrenia on Clozapine Monotherapy
    Wysokinski, A.
    Kowalski, M. L.
    Kloszewska, I.
    [J]. PHARMACOPSYCHIATRY, 2014, 47 (4-5) : 169 - 173
  • [9] A prospective study of serum ghrelin levels in patients treated with clozapine
    Theisen, FM
    Gebhardt, S
    Brömel, T
    Otto, B
    Heldwein, W
    Heinzel-Gutenbrunner, M
    Krieg, JC
    Remschmidt, H
    Tschöp, M
    Hebebrand, J
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (10) : 1411 - 1416
  • [10] A prospective study of serum ghrelin levels in patients treated with clozapine
    F. M. Theisen
    S. Gebhardt
    T. Brömel
    B. Otto
    W. Heldwein
    M. Heinzel-Gutenbrunner
    J.-C. Krieg
    H. Remschmidt
    M. Tschöp
    J. Hebebrand
    [J]. Journal of Neural Transmission, 2005, 112 : 1411 - 1416